268 related articles for article (PubMed ID: 25332316)
1. Association of indoxyl sulfate with heart failure among patients on hemodialysis.
Cao XS; Chen J; Zou JZ; Zhong YH; Teng J; Ji J; Chen ZW; Liu ZH; Shen B; Nie YX; Lv WL; Xiang FF; Tan X; Ding XQ
Clin J Am Soc Nephrol; 2015 Jan; 10(1):111-9. PubMed ID: 25332316
[TBL] [Abstract][Full Text] [Related]
2. Indoxyl Sulfate and Incident Peripheral Artery Disease in Hemodialysis Patients.
Lin TY; Chou HH; Huang HL; Hung SC
Toxins (Basel); 2020 Nov; 12(11):. PubMed ID: 33147880
[TBL] [Abstract][Full Text] [Related]
3. Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.
Wang CH; Cheng ML; Liu MH; Shiao MS; Hsu KH; Huang YY; Lin CC; Lin JF
Heart Vessels; 2016 Jul; 31(7):1100-8. PubMed ID: 26135926
[TBL] [Abstract][Full Text] [Related]
4. Serum indoxyl sulfate is associated with mortality in hospital-acquired acute kidney injury: a prospective cohort study.
Wang W; Hao G; Pan Y; Ma S; Yang T; Shi P; Zhu Q; Xie Y; Ma S; Zhang Q; Ruan H; Ding F
BMC Nephrol; 2019 Feb; 20(1):57. PubMed ID: 30764800
[TBL] [Abstract][Full Text] [Related]
5. Association of trimethylamine
Zhang P; Zou JZ; Chen J; Tan X; Xiang FF; Shen B; Hu JC; Wang JL; Wang YQ; Yu JB; Nie YX; Chen XH; Yu JW; Zhang Z; Lv WL; Xie YQ; Cao XS; Ding XQ
Ren Fail; 2020 Nov; 42(1):1004-1014. PubMed ID: 32985309
[TBL] [Abstract][Full Text] [Related]
6. Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts.
Wu CC; Hsieh MY; Hung SC; Kuo KL; Tsai TH; Lai CL; Chen JW; Lin SJ; Huang PH; Tarng DC
J Am Soc Nephrol; 2016 Apr; 27(4):1254-64. PubMed ID: 26453609
[TBL] [Abstract][Full Text] [Related]
7. Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.
Bataille S; Pelletier M; Sallée M; Berland Y; McKay N; Duval A; Gentile S; Mouelhi Y; Brunet P; Burtey S
BMC Nephrol; 2017 Jul; 18(1):251. PubMed ID: 28747155
[TBL] [Abstract][Full Text] [Related]
8. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
Shafi T; Sirich TL; Meyer TW; Hostetter TH; Plummer NS; Hwang S; Melamed ML; Banerjee T; Coresh J; Powe NR
Kidney Int; 2017 Dec; 92(6):1484-1492. PubMed ID: 28739139
[TBL] [Abstract][Full Text] [Related]
9. Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients.
Taki K; Tsuruta Y; Niwa T
Am J Nephrol; 2007; 27(1):30-5. PubMed ID: 17215572
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up.
Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
Arch Med Res; 2013 Oct; 44(7):535-41. PubMed ID: 24055267
[TBL] [Abstract][Full Text] [Related]
11. Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease.
Lin CJ; Liu HL; Pan CF; Chuang CK; Jayakumar T; Wang TJ; Chen HH; Wu CJ
Arch Med Res; 2012 Aug; 43(6):451-6. PubMed ID: 22885091
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Utility of Indoxyl Sulfate for Patients with Acute Coronary Syndrome.
Watanabe I; Tatebe J; Fujii T; Noike R; Saito D; Koike H; Yabe T; Okubo R; Nakanishi R; Amano H; Toda M; Ikeda T; Morita T
J Atheroscler Thromb; 2019 Jan; 26(1):64-71. PubMed ID: 29780075
[TBL] [Abstract][Full Text] [Related]
13. Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children.
Holle J; Kirchner M; Okun J; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Duzova A; Ranchin B; Shroff R; Candan C; Oh J; Klaus G; Lugani F; Gimpel C; Büscher R; Yilmaz A; Baskin E; Erdogan H; Zaloszyc A; Özcelik G; Drozdz D; Jankauskiene A; Nobili F; Melk A; Querfeld U; Schaefer F;
PLoS One; 2020; 15(10):e0240446. PubMed ID: 33108385
[TBL] [Abstract][Full Text] [Related]
14. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.
Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905
[TBL] [Abstract][Full Text] [Related]
15. Impact of Indoxyl Sulfate on Coronary Plaques in Patients on Hemodialysis.
Asami M; Tanabe K; Ito S; Yoshida E; Aoki J; Tanimoto S; Horiuchi Y; Yoshida M
Int Heart J; 2018 May; 59(3):489-496. PubMed ID: 29743417
[TBL] [Abstract][Full Text] [Related]
16. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators.
Melamed ML; Plantinga L; Shafi T; Parekh R; Meyer TW; Hostetter TH; Coresh J; Powe NR
BMC Nephrol; 2013 Jun; 14():134. PubMed ID: 23806101
[TBL] [Abstract][Full Text] [Related]
17. High-volume hemodiafiltration decreases the pre-dialysis concentrations of indoxyl sulfate and p-cresyl sulfate compared to hemodialysis: a post-hoc analysis from the HDFit randomized controlled trial.
Lima JD; Guedes M; Rodrigues SD; Flórido ACS; Moreno-Amaral AN; Barra AB; Canziani ME; Cuvello-Neto A; Poli-de-Figueiredo CE; Pecoits-Filho R; Nakao LS
J Nephrol; 2022 Jun; 35(5):1449-1456. PubMed ID: 35239175
[TBL] [Abstract][Full Text] [Related]
18. High Uric Acid Ameliorates Indoxyl Sulfate-Induced Endothelial Dysfunction and Is Associated with Lower Mortality among Hemodialysis Patients.
Hsu WL; Li SY; Liu JS; Huang PH; Lin SJ; Hsu CC; Lin YP; Tarng DC
Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28067806
[TBL] [Abstract][Full Text] [Related]
19. Indoxyl-beta-D-glucuronide and 3-indoxyl sulfate in plasma of hemodialysis patients.
Agatsuma S; Sekino H; Watanabe H
Clin Nephrol; 1996 Apr; 45(4):250-6. PubMed ID: 8861801
[TBL] [Abstract][Full Text] [Related]
20. Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure.
Sens F; Schott-Pethelaz AM; Labeeuw M; Colin C; Villar E
Kidney Int; 2011 Nov; 80(9):970-977. PubMed ID: 21775972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
